BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 24495391)

  • 1. Bithionol inhibits ovarian cancer cell growth in vitro - studies on mechanism(s) of action.
    Ayyagari VN; Brard L
    BMC Cancer; 2014 Feb; 14():61. PubMed ID: 24495391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines.
    Ayyagari VN; Hsieh TJ; Diaz-Sylvester PL; Brard L
    BMC Cancer; 2017 Jan; 17(1):49. PubMed ID: 28086831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines.
    Ayyagari VN; Diaz-Sylvester PL; Hsieh TJ; Brard L
    PLoS One; 2017; 12(9):e0185111. PubMed ID: 28931042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the antitumor potential of Bithionol in vivo using a xenograft model of ovarian cancer.
    Ayyagari VN; Johnston NA; Brard L
    Anticancer Drugs; 2016 Jul; 27(6):547-59. PubMed ID: 27058706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dioscin-6'-O-acetate inhibits lung cancer cell proliferation via inducing cell cycle arrest and caspase-dependent apoptosis.
    Li X; Qu Z; Jing S; Li X; Zhao C; Man S; Wang Y; Gao W
    Phytomedicine; 2019 Feb; 53():124-133. PubMed ID: 30668391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 10
    Zhang J; Ming C; Zhang W; Okechukwu PN; Morak-Młodawska B; Pluta K; Jeleń M; Akim AM; Ang KP; Ooi KK
    Drug Des Devel Ther; 2017; 11():3045-3063. PubMed ID: 29123378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The O-methylated isoflavone, formononetin, inhibits human ovarian cancer cell proliferation by sub G0/G1 cell phase arrest through PI3K/AKT and ERK1/2 inactivation.
    Park S; Bazer FW; Lim W; Song G
    J Cell Biochem; 2018 Sep; 119(9):7377-7387. PubMed ID: 29761845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.
    Liu M; Qi Z; Liu B; Ren Y; Li H; Yang G; Zhang Q
    Oncotarget; 2015 Sep; 6(28):25281-94. PubMed ID: 26325371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer activity of ursolic acid on human ovarian cancer cells via ROS and MMP mediated apoptosis, cell cycle arrest and downregulation of PI3K/AKT pathway.
    Lin W; Ye H
    J BUON; 2020; 25(2):750-756. PubMed ID: 32521863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytisine exerts anti-tumour effects on lung cancer cells by modulating reactive oxygen species-mediated signalling pathways.
    Xu WT; Li TZ; Li SM; Wang C; Wang H; Luo YH; Piao XJ; Wang JR; Zhang Y; Zhang T; Xue H; Cao LK; Jin CH
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):84-95. PubMed ID: 31852250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. δ-Tocotrienol sensitizes and re-sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK-mediated apoptosis.
    Fontana F; Marzagalli M; Raimondi M; Zuco V; Zaffaroni N; Limonta P
    Cell Prolif; 2021 Nov; 54(11):e13111. PubMed ID: 34520051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Berberine-photodynamic therapy sensitizes melanoma cells to cisplatin-induced apoptosis through ROS-mediated P38 MAPK pathways.
    Wang X; Gong Q; Song C; Fang J; Yang Y; Liang X; Huang X; Liu J
    Toxicol Appl Pharmacol; 2021 May; 418():115484. PubMed ID: 33716044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 3-deoxysappanchalcone induces ROS-mediated apoptosis and cell cycle arrest via JNK/p38 MAPKs signaling pathway in human esophageal cancer cells.
    Kwak AW; Lee MJ; Lee MH; Yoon G; Cho SS; Chae JI; Shim JH
    Phytomedicine; 2021 Jun; 86():153564. PubMed ID: 33895649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 7-O-Geranylquercetin induces apoptosis in gastric cancer cells via ROS-MAPK mediated mitochondrial signaling pathway activation.
    Zhu Y; Jiang Y; Shi L; Du L; Xu X; Wang E; Sun Y; Guo X; Zou B; Wang H; Wang C; Sun L; Zhen Y
    Biomed Pharmacother; 2017 Mar; 87():527-538. PubMed ID: 28076833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
    Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
    Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetraarsenic hexoxide induces G2/M arrest, apoptosis, and autophagy via PI3K/Akt suppression and p38 MAPK activation in SW620 human colon cancer cells.
    Nagappan A; Lee WS; Yun JW; Lu JN; Chang SH; Jeong JH; Kim GS; Jung JM; Hong SC
    PLoS One; 2017; 12(3):e0174591. PubMed ID: 28355296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of in vitro and in vivo human ovarian cancer growth by isoacteoside is mediated via sub-G1 cell cycle arrest, ROS generation, and modulation of AKT/PI3K/m-TOR signalling pathway.
    Yang X; Guo F; Peng Q; Liu Y; Yang B
    J BUON; 2019; 24(1):285-290. PubMed ID: 30941982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
    Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
    BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel synthetic analog of Militarin, MA-1 induces mitochondrial dependent apoptosis by ROS generation in human lung cancer cells.
    Yoon DH; Lim MH; Lee YR; Sung GH; Lee TH; Jeon BH; Cho JY; Song WO; Park H; Choi S; Kim TW
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):659-71. PubMed ID: 24161344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phillygenin Exerts In Vitro and In Vivo Antitumor Effects in Drug-Resistant Human Esophageal Cancer Cells by Inducing Mitochondrial-Mediated Apoptosis, ROS Generation, and Inhibition of the Nuclear Factor kappa B NF-κB Signalling Pathway.
    He J; Wei W; Yang Q; Wang Y
    Med Sci Monit; 2019 Jan; 25():739-745. PubMed ID: 30681987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.